b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">\n        <PMID Version="1">31909160</PMID>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>01</Month>\n            <Day>11</Day>\n        </DateRevised>\n        <Article PubModel="Electronic-eCollection">\n            <Journal>\n                <ISSN IssnType="Print">2352-6475</ISSN>\n                <JournalIssue CitedMedium="Print">\n                    <Volume>5</Volume>\n                    <Issue>5</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>Dec</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>International journal of women\'s dermatology</Title>\n                <ISOAbbreviation>Int J Womens Dermatol</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Short-term clinical and serological follow-up with conventional and conformational anti-desmoglein antibodies in treatment-na\xc3\xafve and previously treated patients with pemphigus vulgaris after receiving rituximab.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>372-377</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijwd.2019.05.008</ELocationID>\n            <Abstract>\n                <AbstractText Label="Background" NlmCategory="UNASSIGNED">Pemphigus vulgaris (PV) is a blistering, life-threatening autoimmune disease. Ethylenediaminetetraacetic acid (EDTA)-treated desmoglein (Dsg) enzyme-linked immunosorbent assay (ELISA) has recently been suggested to detect nonpathogenic antibodies. Rituximab (RTX) is now considered a first-line treatment for PV.</AbstractText>\n                <AbstractText Label="Objective" NlmCategory="UNASSIGNED">The primary and secondary aims were to evaluate anti-Dsg and EDTA-treated anti-Dsg ELISA and clinical response before and 3 months after RTX in treatment-na\xc3\xafve and previously treated patients, respectively. In addition, we compared the short-term efficacy of RTX between these groups.</AbstractText>\n                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">Seventy-five patients with PV who received RTX (500 mg weekly for 4 weeks or 1000 mg 2 weeks apart) and prednisolone were followed for 3 months. Thirty-seven treatment-na\xc3\xafve newly diagnosed (group A) and 38 relapsed patients (group B) were included. Disease activity was scored with the Pemphigus Disease Area Index (PDAI). Clinical response was also assessed. Serum samples were collected at two points and examined for anti-Dsg1/3 and EDTA-treated anti-Dsg1/3. Conformational anti-Dsg values were calculated by subtracting EDTA-treated from conventional anti-Dsg values.</AbstractText>\n                <AbstractText Label="Results" NlmCategory="UNASSIGNED">The correlation of conventional and conformational anti-Dsg values was perfect (correlation coefficient &gt; 0.98; <i>p</i> &lt; .001) at every time point for both anti-Dsgs. There was no difference with regard to PDAI and anti-Dsg values between the two groups at baseline. The frequency of responders was significantly higher in group A (100%) than in group B (89%; <i>p</i> = .006). Three patients relapsed, and five patients had persistent disease activity in group B. After 3 months, conventional and conformational anti-Dsg values were significantly higher in group B compared with group A (anti-Dsg3: <i>p</i> = .017 and .021, respectively; anti-Dsg1: <i>p</i> = .014 and .016, respectively). Total and scalp PDAI were significantly lower in group A than in group B (<i>p</i> = .042 and .016, respectively).</AbstractText>\n                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">EDTA-treated anti-Dsg ELISA had no added value. Using RTX as first-line treatment in patients with PV appears to be associated with better clinical response and immunologic profile than delayed treatment in the short term.</AbstractText>\n                <CopyrightInformation>\xc2\xa9 2019 Published by Elsevier Inc. on behalf of Women\'s Dermatologic Society.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Alaeen</LastName>\n                    <ForeName>Hoorieh</ForeName>\n                    <Initials>H</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Autoimmune Bullous Diseases Research Center, Department of Dermatology, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Toosi</LastName>\n                    <ForeName>Roja</ForeName>\n                    <Initials>R</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Autoimmune Bullous Diseases Research Center, Department of Dermatology, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Mahmoudi</LastName>\n                    <ForeName>Hamidreza</ForeName>\n                    <Initials>H</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Autoimmune Bullous Diseases Research Center, Department of Dermatology, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Balighi</LastName>\n                    <ForeName>Kamran</ForeName>\n                    <Initials>K</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Autoimmune Bullous Diseases Research Center, Department of Dermatology, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Tavakolpour</LastName>\n                    <ForeName>Soheil</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Autoimmune Bullous Diseases Research Center, Department of Dermatology, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Teimoupour</LastName>\n                    <ForeName>Amir</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Daneshpazhooh</LastName>\n                    <ForeName>Maryam</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Autoimmune Bullous Diseases Research Center, Department of Dermatology, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>06</Month>\n                <Day>07</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Netherlands</Country>\n            <MedlineTA>Int J Womens Dermatol</MedlineTA>\n            <NlmUniqueID>101654170</NlmUniqueID>\n            <ISSNLinking>2352-6475</ISSNLinking>\n        </MedlineJournalInfo>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">PDAI</Keyword>\n            <Keyword MajorTopicYN="N">Pemphigus vulgaris</Keyword>\n            <Keyword MajorTopicYN="N">anti-desmoglein</Keyword>\n            <Keyword MajorTopicYN="N">ethylenediaminetetraacetic acid-treated desmoglein ELISA</Keyword>\n            <Keyword MajorTopicYN="N">rituximab</Keyword>\n            <Keyword MajorTopicYN="N">treatment</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>12</Month>\n                <Day>02</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2019</Year>\n                <Month>05</Month>\n                <Day>10</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>05</Month>\n                <Day>24</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2020</Year>\n                <Month>1</Month>\n                <Day>8</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2020</Year>\n                <Month>1</Month>\n                <Day>8</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>1</Month>\n                <Day>8</Day>\n                <Hour>6</Hour>\n                <Minute>1</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>epublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31909160</ArticleId>\n            <ArticleId IdType="doi">10.1016/j.ijwd.2019.05.008</ArticleId>\n            <ArticleId IdType="pii">S2352-6475(19)30049-8</ArticleId>\n            <ArticleId IdType="pmc">PMC6938821</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Clin Exp Dermatol. 2014 Jan;39(1):41-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23782219</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Dermatol. 1995 Dec;34(12):865-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">8647669</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int Immunopharmacol. 2019 Jun;71:40-42</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30877872</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Eur Acad Dermatol Venereol. 2007 Nov;21(10):1319-24</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17958835</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Arch Dermatol Res. 2019 Jan;311(1):63-69</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30506422</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Rheum Dis. 2017 Nov;76(11):1829-1836</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28684557</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int Immunopharmacol. 2018 Jan;54:131-138</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29132070</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Am Acad Dermatol. 2018 Feb 10;:null</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29438767</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Acta Derm Venereol. 2015 Apr;95(4):462-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25178305</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Exp Dermatol. 2016 Nov;25(11):839-846</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27305362</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Haematol. 2017 Apr;98(4):371-377</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27981682</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Dermatol Sci. 2013 Jun;70(3):190-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23602628</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Am Acad Dermatol. 2017 Dec;77(6):1074-1082</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28927663</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Am Acad Dermatol. 2016 Jun;74(6):1160-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26896293</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Am Acad Dermatol. 2012 Oct;67(4):623-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22261417</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Am Acad Dermatol. 2008 Jun;58(6):1043-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18339444</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Postepy Dermatol Alergol. 2018 Jun;35(3):293-298</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30008648</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Arch Dermatol. 2009 May;145(5):529-35</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19451496</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Invest Dermatol. 1998 Jan;110(1):76-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">9424092</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Sci Transl Med. 2013 Mar 6;5(175):175ra30</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23467561</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Invest Dermatol. 1991 Feb;96(2):159-61</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">1991976</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet. 2017 May 20;389(10083):2031-2040</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28342637</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Dermatol. 2006 May;45(5):518-22</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16700783</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Acta Derm Venereol. 2014 Mar;94(2):203-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23995461</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Invest Dermatol. 2019 Jan;139(1):31-37</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30301637</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Drugs Dermatol. 2017 Feb 1;16(2):135-139</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28300855</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Am Acad Dermatol. 2002 Nov;47(5):785-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12399777</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Dermatol. 2015 Nov-Dec;25(6):578-85</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26552329</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Front Immunol. 2018 Jun 04;9:1190</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29915578</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Autoimmunity. 2015 Jun;48(4):231-41</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25384535</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Dtsch Dermatol Ges. 2017 Sep;15(9):946-948</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28872241</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Am Acad Dermatol. 2018 Oct;79(4):768-770</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29609015</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Dermatol. 2001 Apr;144(4):775-80</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11298536</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Indian J Dermatol Venereol Leprol. 2006 May-Jun;72(3):203-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16766834</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Am Acad Dermatol. 2015 Aug;73(2):264-71</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26088689</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Iran J Allergy Asthma Immunol. 2009 Mar;8(1):53-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19279360</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Dermatol. 2012 Aug;167(2):252-61</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22404487</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'